Twitter
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PRVB - Provention Bio Could See Meaningful Upside Once Teplizumab Hits The Market
January, 07 2021 02:09 PM
Provention Bio Inc.
Provention Bio is focused on slowing down, or actually preventing in some cases, the onset of autoimmune conditions. Provention's first therapeutic, teplizumab, looks set for approval in mid-2021 in what could be the first of several indicated populations. Provention looks like a good long-term stock to accumulate on any pullbacks as upside if its pipeline comes through could be significant. For further details see:
Provention Bio Could See Meaningful Upside Once Teplizumab Hits The Market
Stock Information
Company Name:
Provention Bio Inc.
Stock Symbol:
PRVB
Market:
NASDAQ
Website:
proventionbio.com
Get PRVB Alerts
News, Short Squeeze, Breakout and More Instantly...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer .